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Abstract Chromosomal translocations are hallmarks of various types of cancers and leukemias.
However, the molecular mechanisms of chromosome translocations remain largely unknown. The
ataxia-telangiectasia mutated (ATM) protein, a DNA damage signaling regulator, facilitates DNA
repair to prevent chromosome abnormalities. Previously, we showed that ATM deficiency led to
the 11q23 chromosome translocation, the most frequent chromosome abnormalities in secondary
leukemia. Here, we show that ARP8, a subunit of the INO80 chromatin remodeling complex, is
phosphorylated after etoposide treatment. The etoposide-induced phosphorylation of ARP8 is
regulated by ATM and ATR, and attenuates its interaction with INO80. The ATM-regulated
phosphorylation of ARP8 reduces the excessive loading of INO80 and RAD51 onto the breakpoint
cluster region. These findings suggest that the phosphorylation of ARP8, regulated by ATM, plays




Chromosome translocations are one of the most common types of genetic rearrangements induced
by DNA damaging agents, such as ionizing radiation and certain chemotherapies. The presence of
disease-specific chromosome translocations, especially in hematological malignancies such as the t
(9;22) or Philadelphia chromosome in chronic myelocytic leukemia, has been reported. Molecular
studies of the breakpoints of such disease-specific chromosome translocations have revealed the
clustering of the breakpoints in specific regions, designated as the breakpoint cluster region (BCR).
In lymphoid malignancies, the involvement of the physiological recombination of immunoglobulin
and T-cell receptor genes in chromosome translocations has been suggested, due to the presence
of signal sequences for the recombination at the breakpoints. However, the molecular mechanisms
of chromosome translocations in other cell types remain largely unknown.
Chromosome translocations arise as a consequence of errors in the repair of DNA double strand
breaks (DSBs). Eukaryotic cells utilize a variety of repair pathways for DSBs, including two major
ones, non-homologous end joining (NHEJ) and homologous recombination repair (HR). In the
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absence of these canonical pathways, the activation of the alternative NHEJ (Alt-EJ) pathway and
the inactivation of DNA polymerase theta are implicated in chromosomal translocations
(Zelensky et al., 2017) (Mizuno et al., 2009; Ruiz et al., 2009; Schmidt et al., 2006). In contrast,
HR is regarded as a precise DSB repair system, since either the intact sister chromatid or the homol-
ogous region is used as the template for repair. However, both the depletion and overexpression of
the RAD51 recombinase, a key factor involved in HR, lead to chromosomal abnormalities
(Reliene et al., 2007; Richardson et al., 2004). Therefore, the precise regulation of the recombina-
tion activity is also required for DNA repair to prevent chromosome translocations.
DNA damage leads to the activation of the DNA damage response and repair pathways. The
ataxia-telangiectasia mutated (ATM) protein regulates the DNA damage response in reaction to
DSBs, through its kinase activity (Clouaire et al., 2017; Guleria and Chandna, 2016; Shiloh, 2003;
Shiloh and Ziv, 2013). Alterations in the function of ATM play pathologic roles in the development
of leukemia/lymphoma and cancer (Khanna, 2000; Oguchi et al., 2003; Reliene et al., 2007). Chro-
mosome translocations involving the MLL gene on 11q23 are the most frequent chromosome abnor-
malities in secondary leukemia associated with chemotherapy employing etoposide, a
topoisomerase II poison. An increase of 11q23 translocations is observed in the ATM kinase activity-
deficient fibroblast cell line AT5BIVA (Nakada et al., 2006). We showed previously that a deficiency
of ATM, a DNA damage signaling kinase, led to the excessive binding of RAD51 and the chromatin
remodeling factor INO80 to the BCR in the MLL gene after etoposide treatment (Sun et al., 2010).
INO80 is conserved in eukaryotes and acts as an integral scaffold for assembling other proteins into
the INO80 chromatin remodeling complex (Chen et al., 2011; Morrison et al., 2004). The INO80
complex plays an important role in chromatin reorganization for transcription (Lafon et al., 2015;
Xue et al., 2015), replication (Falbo and Shen, 2012; Vassileva et al., 2014) and DNA repair
(Alatwi and Downs, 2015; Gospodinov et al., 2011; Morrison et al., 2004; Seeber et al., 2013;
van Attikum et al., 2004). The INO80 complex is required for effective DNA end resection at the
early stage of HR in budding yeast and human cells (Gospodinov et al., 2011; Lademann et al.,
2017; Tsukuda et al., 2005; Tsukuda et al., 2009; van Attikum et al., 2004). Therefore, we specu-
lated that the decreased fidelity of DNA repair by the inappropriate regulation of HR repair in ATM-
deficient cells could lead to chromosomal translocations. However, the mechanism by which ATM
deficiencies induce the excessive binding of INO80 and RAD51 to the BCR after etoposide treat-
ment remains to be clarified.
INO80 forms a chromatin remodeling complex with more than 15 subunits (Jin et al., 2005;
Shen et al., 2000). Among the subunits of the INO80 complex, ARP8 functions as a nucleosome rec-
ognition module and enhances the nucleosome-binding affinity of the protein complex
(Saravanan et al., 2012; Shen et al., 2003). In this study, we found that ARP8 is required for the
binding of INO80 and RAD51 to the BCR in the MLL gene after etoposide treatment. We also
showed that the DNA damage-dependent phosphorylation of ARP8 is regulated by ATM and ATR
after etoposide treatment. The ATM-dependent phosphorylation of ARP8 negatively regulates the
interaction between INO80 and ARP8, leading to the reduced binding of INO80 and RAD51 to the
BCR after etoposide treatment. In contrast, ATR was not involved in the regulation of the etoposide-
induced binding of RAD51 to the BCR. These findings suggest that ATM plays distinct roles from
ATR in the phosphorylation of ARP8 to prevent the etoposide-induced 11q23 chromosome translo-
cations, through the negative regulation of INO80 and RAD51 binding to the BCR.
Results
Phosphorylation of ARP8 after etoposide treatment regulated by ATM
and ATR
In our previous study, we showed that ATM deficiency resulted in the overloading of INO80 and
RAD51 onto the BCR of the MLL gene after etoposide treatment (Sun et al., 2010). The finding led
us to investigate the phosphorylation target of the ATM kinase, which could regulate the loading of
INO80 and RAD51 onto the BCR. First, we examined the phosphorylation status of INO80 after eto-
poside treatment. However, we could not detect the phosphorylation of INO80 by ATM after etopo-
side treatment by an immunoblotting analysis (Figure 1—figure supplement 1A). Therefore, we
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Figure 1. Identification of etoposide-induced ARP8 phosphorylation and the possible responsible kinase. (A) Amino acid sequence 408 through 420 of
ARP8. The Ser412 residue, within the ATM/ATR substrate motif and the CK2 substrate motif, is indicated. (B) Immunoprecipitation analysis of ARP8
phosphorylation. U2OS cells transiently expressing an empty HA vector or a vector encoding HA-tagged ARP8 were treated with DMSO (ctrl) or
etoposide (Etp) for 15 min, then washed twice and cultured in complete medium for the indicated times. The nuclear extracts were incubated with anti-
Figure 1 continued on next page
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decided to examine the phosphorylation of the subunits of the INO80 protein complex after etopo-
side treatment.
The substrates of ATM contain the core sequence with an SQ or TQ motif (Kim et al., 1999;
Matsuoka et al., 2007; O’Neill et al., 2000). By searching for SQ or TQ motifs in the subunits of the
INO80 complex, we found that APR8 had an SQ motif at S412 and Q413. This motif in ARP8 is indi-
cated as a putative phosphorylation site in the PhosphoSitePlus database (Figure 1A and Figure 1—
figure supplement 1B–D). ARP8 is required for DNA binding by INO80 in yeast and mammals, and
the ARP8 knockout in human cells impairs the binding of INO80 to chromatin and causes defects in
DNA repair (Kashiwaba et al., 2010; Saravanan et al., 2012). Therefore, we examined whether
ARP8 was the phosphorylation target of ATM. The immunoblotting analysis, using antibodies against
the ATM/ATR substrate, revealed that the level of ARP8 phosphorylation was significantly increased
from 2 hr after etoposide treatment (Figure 1B). The disappearance of the signal by a protein phos-
phatase treatment validated that the derived signal resulted from the phosphorylation of ARP8
(Figure 1B).
To confirm that Ser412 is the site in ARP8 that is phosphorylated after etoposide treatment, we
produced an ARP8 mutant by replacing Ser412 with alanine. An immunoprecipitation analysis
revealed that the etoposide-induced phosphorylation was completely abolished by the S412A sub-
stitution, indicating that Ser412 is the sole site within ARP8 that is phosphorylated in response to
etoposide treatment (Figure 1C).
Next to investigate whether the etoposide-induced phosphorylation of ARP8 is regulated by
ATM, we compared the phosphorylation status of ARP8 in ATM-deficient BIVA and ATM-proficient
11–4 cells after etoposide treatment. An immunoblotting analysis revealed that the etoposide-
induced ARP8 phosphorylation in BIVA cells was lower than that in 11–4 cells (Figure 1D). Moreover,
the phosphorylation of ARP8 in ATM-proficient 11–4 cells after etoposide treatment was repressed
by the ATM-specific inhibitor, KU55933 (ATMi) (Figure 1E; lanes 1–8). These findings suggest that
ATM regulates the ARP8 phosphorylation after etoposide treatment. The dose-dependent repres-
sion of the etoposide-induced ARP8 phosphorylation by ATMi in U2OS cells further supported this
notion (Figure 1—figure supplement 2A).
Since ATMi did not completely abolish the etoposide-induced phosphorylation of ARP8, we next
examined the relevance of ATR, another PI3-family kinase member sharing the same phosphoryla-
tion motif with ATM. ATR is responsible for the phosphorylation in the DNA replication stress
response, and is activated by ATM after ionizing radiation (Cuadrado et al., 2006; Jazayeri et al.,
2006; Myers and Cortez, 2006). The etoposide-induced phosphorylation of ARP8 was strongly
Figure 1 continued
HA-conjugated anti-mouse IgG Dynabeads. The precipitates were electrophoresed through a gel and probed by western blotting with an anti-ATM/
ATR substrate antibody or an anti-HA antibody. lPPase treatment identified the band of phosphorylated HA-ARP8. The blot of input was probed by
antibodies against phospho-ATM (p-ATM), g H2AX or phospho-RPA2 at Ser4/8 (p-RPA2). b-actin was used as a loading control. (C) Identification of the
ARP8 phosphorylation site by an immunoprecipitation analysis. U2OS cells were transfected with an empty HA vector (vet), or a vector encoding HA-
tagged wild-type ARP8 (WT) or HA-ARP8 S412A (S412A) for 48 hr. The cells were washed after treatment with etoposide or DMSO for 15 min, cultured
in fresh medium, and harvested at the indicated time points. Whole cell extracts were used for the immunoprecipitation analysis. (D) Etoposide-induced
ARP8 phosphorylation in ATM-deficient BIVA and ATM-proficient 11–4 cells. Immunoprecipitation analysis of cell extracts of BIVA or 11–4 cells
transfected with HA-tagged wild-type ARP8 using anti-HA antibodies. The cells were treated with DMSO (ctrl) or etoposide (Etp) for 15 min, cultured in
fresh medium, and harvested at the indicated time points. Whole cell extracts were used for the immunoprecipitation analysis, which was performed as
described in (B). The amounts of phosphorylated ARP8 and HA-ARP8 were quantified, using the Image J software. The results of the quantitative
analysis are shown as the relative values to the DMSO controls. Source data are presented in Figure 1—source data 1. (E) Immunoprecipitation
analysis of cell extracts from 11 to 4 cells expressing HA-tagged ARP8. The cells were treated with DMSO, 10 mM ATMi (KU55933), or 10 mM ATRi
(VE821) for 2 hr before etoposide treatment, and then the inhibitors (5 mM) were added after the cells were washed.
DOI: https://doi.org/10.7554/eLife.32222.002
The following source data and figure supplements are available for figure 1:
Source data 1. Source raw data for Figure 1D.
DOI: https://doi.org/10.7554/eLife.32222.005
Figure supplement 1. ARP8 contains an ATM/ATR substrate SQ motif at Ser412 and Q413.
DOI: https://doi.org/10.7554/eLife.32222.003
Figure supplement 2. ATM, but not CK2 is responsible for ARP8 phosphorylation after etoposide treatment.
DOI: https://doi.org/10.7554/eLife.32222.004
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Figure 2. Phosphorylation of ARP8 negatively regulates the etoposide-induced enrichment of INO80. (A) Schematic representation of the BCR in the
MLL gene. The locations of the primers used in the real-time PCR analyses are shown. The arrow indicates 11q23 chromosome translocation breakpoint
hotspot identified in treatment-related leukemia. Ex: Exon. (B) ChIP analysis of the INO80 loading onto the MLL BCR in endogenous ARP8-depleted11-
4 Flp-In cells expressing either the siRNA-resistant wild-type (WT) or phospho-deficient ARP8 (S412A) after tetracycline treatment. The cells were
Figure 2 continued on next page
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repressed by the ATR inhibitor VE821 (ATRi) in 11–4 cells (Figure 1E, lanes 9–12). This finding sug-
gests that ATR is the major kinase responsible for etoposide-induced ARP8 phosphorylation. In con-
trast, casein kinase 2, another kinase involved in the DNA damage response (Olsen et al., 2012)
(Guerra et al., 2014) was not involved in the phosphorylation of ARP8 after etoposide treatment
(Figure 1—figure supplement 2B). Together, these findings suggest that the phosphorylation of
ARP8 at S412 after etoposide treatment is regulated by ATM and ATR.
Negative regulation of the etoposide-induced loading of INO80 onto
the MLL BCR by the phosphorylation of ARP8
Having established that ARP8 is phosphorylated after etoposide treatment, we investigated the role
of ARP8 in INO80 loading onto the MLL BCR (Figure 2A). The enrichment of gH2AX on BCR was
observed in ATM-proficient 11–4 cells after etoposide treatment, suggesting that etoposide induces
DNA damage specifically at the BCR (Figure 2—figure supplement 1A). A chromatin immunopre-
cipitation (ChIP) analysis revealed that the depletion of ARP8 reduced the binding of INO80 to the
BCR after etoposide treatment in BIVA cells ((Figure 2—figure supplement 1B). Since the depletion
of ARP8 did not affect the levels of INO80 (Figure 2—figure supplement 1C), the result suggests
that ARP8 is required for loading INO80 onto the MLL BCR after etoposide treatment in BIVA cells.
Next, to explore the role of ARP8 phosphorylation in the regulation of INO80 loading onto the BCR
after etoposide treatment, we generated ATM-proficient 11–4 cell lines expressing the siRNA-resis-
tant wild-type ARP8 (WT) or the phosphorylation-deficient mutant S412A (Figure 2—figure supple-
ment 2A). The ChIP analysis revealed that the expression of the S412A mutant in ATM-proficient
cells increased the binding of INO80 to the BCR after etoposide treatment (Figure 2B). Moreover,
ATMi treatment increased the binding of INO80 to the BCR after etoposide treatment in ATM-profi-
cient cells expressing wild-type ARP8 (Figure 2C). These findings suggest that the etoposide-
induced phosphorylation of ARP8 represses the binding of INO80 to the BCR. Importantly, the ATMi
treatment failed to enhance the enrichment of INO80 at the BCR in ATM-proficient 11–4 cells
expressing the ARP8 S412A mutant (Figure 2D). This suggests that ARP8 phosphorylation at S412
regulated by ATM is responsible for the excessive binding of INO80 at the BCR after etoposide
treatment. To further confirm the repression of the INO80 binding to the BCR by the ARP8 phos-
phorylation, we next introduced the siRNA-resistant phosphomimetic mutant S412D into the ATM-
Figure 2 continued
treated with DMSO (ctrl) or etoposide for 15 min, washed, and then cultured in fresh medium for 1 or 2 hr. GAPDH is shown as the control region.
Values represent the means ± SE from three independent experiments. *: p<0.05. Source data are presented in Figure 2—source data 1. (C) ChIP
analysis of the INO80 loading onto the MLL BCR in wild-type ARP8 expressing11-4 Flp-In cells. The cells were treated with/without an ATM inhibitor
(KU55933) for 2 hr before etoposide treatment, and then the inhibitors (5 mM) were added after the cells were washed. The experiment was performed
as described in (B). Values represent the means ± SE from three independent experiments. *: p<0.05. The level of ATM phosphorylation or expression
of INO80 was shown in Figure 2—figure supplement 2B. Source data are presented in Figure 2—source data 1. (D) ChIP analysis of the INO80
loading onto the MLL BCR in S412A ARP8 expressing 11–4 Flp-In cells. The cells were treated with/without 10 mM ATM inhibitor for 2 hr before
etoposide treatment, and then the inhibitors (5 mM) were added after the cells were washed. The experiment was performed as described in (B). Values
represent the means ± SE from three independent experiments. n.s: no significant difference. The levels of ATM phosphorylation and INO80 expression
are shown in Figure 2—figure supplement 2C. Source data are presented in Figure 2—source data 1. (E) ChIP analysis of the INO80 loading onto
the MLL BCR in endogenous ARP8-depleted BIVA cells transfected with either the siRNA-resistant wild-type (WT) or phospho-mimetic ARP8(S412D).
The control cells were transfected with an empty vector and a non-targeting siRNA (vet). The cells were treated with DMSO (ctrl) or etoposide for 15
min, washed, and then cultured in fresh medium for 1 hr. Values represent the means ± SE from three independent experiments. *p<0.05, n.a: not
analyzed. Source data are presented in Figure 2—source data 1.
DOI: https://doi.org/10.7554/eLife.32222.006
The following source data and figure supplements are available for figure 2:
Source data 1. Source raw data for Figure 2B-E.
DOI: https://doi.org/10.7554/eLife.32222.009




Figure supplement 2. Establishment of stable and inducible ARP8 expressing 11–4 Flp-In cells.
DOI: https://doi.org/10.7554/eLife.32222.008
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Figure 3. ARP8 phosphorylation deficiency increased its interaction with INO80. (A) Immunoprecipitation analysis of the interaction between INO80 and
ARP8 in ATM inhibitor treated U2OS cells. The cells were treated with 10 mM KU55933 (ATMi) or equal amounts of DMSO (mock) for 2 hr, and then
treated with DMSO (ctrl) or etoposide for 15 min, washed, and then cultured in fresh medium with or without 5 mM KU55933 for 2 hr.
Immunoprecipitation analysis was performed with either anti-ARP8 antibodies or normal IgG. The relative immunoprecipitated amounts of INO80 are
Figure 3 continued on next page
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deficient BIVA cells. Consistently, the expression of the phosphomimetic mutant S412D in BIVA cells
reduced the binding of INO80 to the BCR after etoposide treatment (Figure 2E). Taken together,
these results indicate that the phosphorylation of ARP8 represses the loading of INO80 onto the
MLL BCR in response to etoposide-induced damage.
Phosphorylation of ARP8 regulates its interaction with INO80
To determine whether the phosphorylation of ARP8 affects the loading of INO80 onto the MLL BCR
through its interaction with INO80, we performed an immunoprecipitation analysis using U2OS cells.
We found that etoposide treatment increased the interaction between INO80 and ARP8 in the ATM-
proficient U2OS cells (Figure 3A). The etoposide-induced interaction between INO80 and ARP8 was
enhanced by the treatment of U2OS cells with an ATM inhibitor (Figure 3A). These findings raised
the possibility that ATM negatively regulates the interaction of ARP8 with INO80 after etoposide
treatment. Therefore, we investigated the role of the ATM-regulated phosphorylation of ARP8 in the
interaction between ARP8 and INO80 after etoposide treatment by using the U2OS cells stably
expressing the phosphorylation-deficient ARP8 S412A mutant. An immunoprecipitation analysis
showed an increased level of interaction of the ARP8 S412A mutant with INO80 after etoposide
treatment, as compared to that of wild-type ARP8 (ARP8 WT) in ATM-proficient cells (Figure 3B).
Similar results were obtained using the U2OS cells transiently expressing the ARP8 S412A mutant
(Figure 3—figure supplement 1A). These findings support the notion that the phosphorylation of
ARP8 represses its interaction with INO80 after etoposide treatment. To confirm the repression of
the association of ARP8 with INO80 by ATM, we transiently expressed HA-tagged ARP8 WT or
S412D mutant in ATM-deficient BIVA cells. An immunoprecipitation analysis revealed the increased
interaction of INO80 with ARP8 WT, but not with the S412D mutant, in ATM-deficient BIVA cells
after etoposide treatment (Figure 3—figure supplement 1B). A proximity ligation assay confirmed
the decreased interaction of INO80 with the ARP8 S412D mutant (Figure 3—figure supplement 2).
Taken together, these findings suggest that the phosphorylation of ARP8 represses the interaction
between INO80 and ARP8 after etoposide treatment.
ARP8 phosphorylation negatively regulates RAD51 loading onto the
BCR after etoposide treatment
In our previous study, we detected the excess loading of RAD51 onto the BCR of the MLL gene in
etoposide-treated ATM-deficient BIVA cells (Sun et al., 2010). In yeast, INO80 promotes DNA end
resection and RAD51 binding to ssDNA for homology search/invasion during HR (Lademann et al.,
2017; Tsukuda et al., 2009). To explore the mechanism of excessive RAD51 loading on the BCR,
Figure 3 continued
shown. Quantitative analysis was performed using the Image J software. (B) Examination of the interaction between INO80 and ARP8 in U2OS cells
expressing HA-tagged wild-type or S412A ARP8. The endogenous ARP8-depleted cells were treated with etoposide for 15 min. After the cells were
washed, they were placed in fresh medium and harvested at the indicated time points. The nuclear extracts were incubated with anti-HA-conjugated
anti-mouse IgG Dynabeads. The precipitates were electrophoresed through a gel and probed by western blotting with an anti-INO80 or an anti-HA or
an anti-ATM/ATR substrate antibody. The amounts of INO80 and HA-ARP8 were quantified, using the Image J software. The results of quantitative
analysis are shown as the relative values as compared to the DMSO control from three independent experiments. Source data are presented in
Figure 3—source data 1.
DOI: https://doi.org/10.7554/eLife.32222.011
The following source data and figure supplements are available for figure 3:
Source data 1. Source raw data for Figure 3B.
DOI: https://doi.org/10.7554/eLife.32222.014
Source data 2. Source raw data for Figure 3—figure supplement 1B.
DOI: https://doi.org/10.7554/eLife.32222.015
Source data 3. Source raw data for Figure 3—figure supplement 2B.
DOI: https://doi.org/10.7554/eLife.32222.016
Figure supplement 1. Examination of the interaction between ARP8 and INO80.
DOI: https://doi.org/10.7554/eLife.32222.012
Figure supplement 2. Examination of ARP8-INO80 interactions using Proximity ligation assay.
DOI: https://doi.org/10.7554/eLife.32222.013
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Figure 4. ARP8 phosphorylation prevents the excessive RAD51 loading onto MLL BCR. (A) ChIP analysis of the RAD51 loading onto the MLL BCR in
endogenous ARP8-depleted11-4 Flp-In cells expressing the siRNA-resistant wild-type (WT) or phospho-deficient ARP8 (S412A) after tetracycline
treatment. The cells were treated with DMSO (ctrl) or etoposide for 15 min, washed, and then cultured in fresh medium for 1 or 2 hr. Values represent
the means ± SE from three independent experiments. **: p<0.01. Source data are presented in Figure 4—source data 1. (B) ChIP analysis of the
Figure 4 continued on next page
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we examined the involvement of INO80 in RAD51 binding to damaged chromatin. A ChIP assay
revealed that the depletion of INO80 by siRNA reduced the loading of RAD51 onto the MLL BCR in
BIVA cells after etoposide treatment, suggesting that human INO80 promotes RAD51 binding to
the BCR (Figure 4—figure supplement 1A and B). We next investigated the requirement for ARP8
in RAD51 binding to the MLL BCR. A ChIP analysis showed that the depletion of ARP8 reduced the
binding of RAD51 to the MLL BCR in BIVA cells after etoposide treatment (Figure 4—figure supple-
ment 1C). Since the depletion of ARP8 did not affect the level of RAD51 (Figure 2—figure supple-
ment 1C), these findings suggest the involvement of ARP8 in the excessive binding of RAD51 to the
BCR in BIVA cells.
We then studied the effect of ARP8 phosphorylation on the regulation of RAD51 binding to the
BCR after etoposide treatment. The expression of the ARP8 phosphorylation-deficient mutant
S412A increased the RAD51 binding to the BCR of the MLL gene after etoposide treatment in ATM-
proficient cells (Figure 4A). In ATM-proficient cells, ATMi treatment resulted in an increase of
RAD51 binding to the BCR (Figure 4B), but it did not cause a further increase of RAD51 when ARP8
S412A was expressed (Figure 4C). In contrast, the expression of the ARP8 phosphomimetic mutant
S412D in ATM-deficient BIVA cells repressed the excessive binding of RAD51 to the BCR
(Figure 4D). These results strongly suggest that ARP8 phosphorylation at S412 represses the loading
of RAD51 onto the MLL BCR after etoposide treatment. Taken together, the phosphorylation of
ARP8 regulated by ATM may negatively regulate the loading of RAD51 onto the BCR after etopo-
side treatment, by repressing the loading of the INO80 complex.
Repression of 11q23 chromosome translocations through the
phosphorylation of ARP8
Having established that ARP8 regulates the loading of RAD51 and INO80 onto the BCR after etopo-
side treatment, we decided to examine the involvement of ARP8 in 11q23 chromosome transloca-
tions. A two-color fluorescence in situ hybridization (FISH) analysis, covering the upstream and
downstream regions of the MLL BCR, revealed that the number of BIVA cells carrying split FISH sig-
nals after etoposide treatment was significantly reduced by the siRNA-mediated depletion of ARP8,
suggesting the involvement of ARP8 in 11q23 chromosomal abnormalities in ATM-deficient cells
(Figure 5A and B). This finding was confirmed by the FISH analysis with a different DNA probe set
(Figure 5—figure supplement 1A). In contrast, the number of split signal positive cells among the
ATM-proficient 11–4 cells was increased by the depletion of ARP8 (Figure 5B). This was confirmed
by the FISH analysis of ARP8-deficient Nalm-6 cells (Figure 5—figure supplement 1B). These find-
ings suggest that ATM prevents the etoposide-induced 11q23 chromosome translocations through
the regulation of ARP8.
Figure 4 continued
RAD51 loading onto the MLL BCR in wild-type ARP8 expressing 11–4 cells. Following a treatment with/without 10 mM ATM inhibitor (KU55933) for 2 hr,
the cells were treated with DMSO (ctrl) or etoposide for 15 min, washed, and then cultured in fresh medium with or without 5 mM KU55933 for 1 or 2 hr.
Values represent the means ± SE from three independent experiments. *p<0.05. The levels of ATM phosphorylation and expression of RAD51 are
shown in Figure 2—figure supplement 2B. Source data are presented in Figure 4—source data 1. (C) ChIP analysis of the RAD51 loading onto the
MLL BCR in S412A ARP8 mutant expressing 11–4 Flp-In cells. The experiment was performed as described in (B). Values represent the means ± SE from
three independent experiments. n.s: no significant difference. The levels of ATM phosphorylation and RAD51 expression are shown in Figure 2—figure
supplement 2C. Source data are presented in Figure 4—source data 1. (D) ChIP analysis of the RAD51 loading onto the MLL BCR in endogenous
ARP8-depleted BIVA cells transfected with either the siRNA-resistant wild-type (WT) or phospho-mimetic ARP8 (S412D). GAPDH is shown as the control
region. The control cells were transfected with the empty vector and the non-targeting siRNA (vet). Values represent the means ± SE from three
independent experiments. *p<0.05. n.a: not analyzed. Source data are presented in Figure 4—source data 1.
DOI: https://doi.org/10.7554/eLife.32222.017
The following source data and figure supplement are available for figure 4:
Source data 1. Source raw data for Figure 4A-D.
DOI: https://doi.org/10.7554/eLife.32222.019
Source data 2. Source raw data for Figure 4—figure supplement 1B and C.
DOI: https://doi.org/10.7554/eLife.32222.020
Figure supplement 1. Requirement of INO80 and ARP8 for RAD51 binding to the BCR of the MLL gene.
DOI: https://doi.org/10.7554/eLife.32222.018
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Figure 5. ARP8 phosphorylation averts 11q23 chromosome translocations. (A) Dual-color FISH analysis of chromosome 11q23. Representative FISH
images using etoposide treated BIVA cells are shown. Arrows indicate the split signals (separated by >1 mm). Scale bar: 5 mm. (B) The percentages of
Figure 5 continued on next page
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Next, to investigate the role of the ATM-dependent phosphorylation of ARP8 in preventing the
11q23 chromosome abnormalities, we performed the FISH analysis of ATM-deficient BIVA cells
expressing the phospho-mimicking ARP8 S412D mutant. The FISH analysis revealed that the expres-
sion of ARP8 S412D reduced the number of cells exhibiting split FISH signals after etoposide treat-
ment in ATM-deficient cells (Figure 5C). In contrast, the expression of the phospho-deficient ARP8
S412A mutant increased the incidence of 11q23 chromosome translocations in ATM-proficient 11–4
cells (Figure 5D). Notably, ATMi treatment failed to enhance the event in ARP8 S412A mutant
expressing cells (Figure 5E). Taken together, these findings strongly suggest that the ATM-depen-
dent phosphorylation of ARP8 is required to prevent the etoposide-induced 11q23 chromosome
abnormalities, through the negative regulation of RAD51 and INO80 binding to the BCR.
ATM, but not ATR, negatively regulates RAD51 loading onto the BCR
after etoposide treatment to repress 11q23 chromosome
translocations
Since the etoposide-induced phosphorylation of ARP8 was strongly repressed by an ATR inhibitor in
11–4 cells (Figure 1E), the ATR-dependent phosphorylation of ARP8 could also be involved in the
excessive RAD51 loading onto the BCR. To test this possibility, we performed a chromatin immuno-
precipitation assay of 11–4 cells treated with the ATR inhibitor, VE821. In contrast to the significant
increase of etoposide-induced RAD51 binding to the BCR by the treatment with the ATM inhibitor,
ATR inhibition failed to so (Figure 6A). These results suggest that ATR is not involved in the regula-
tion of RAD51 binding at the BCR of MLL after etoposide treatment.
Next, we examined the effect of an ATRi on the etoposide-induced 11q23 chromosome translo-
cations in ATM-proficient 11–4 cells, by the dual color FISH analysis using the MLL gene probes
(Figure 6B). The increase of the split signal positive cells by ATRi was less than that by ATMi.
Although ATR is suggested to be the major kinase responsible for ARP8 phosphorylation after eto-
poside treatment, this finding suggests that the effect of ATRi on the etoposide-induced chromo-
some translocations is limited. Moreover, no additional effects of ATRi on the increase of the
chromosome translocations by ATMi were observed. Taken together, these findings strongly sug-
gest that ATM, but not ATR, negatively regulates RAD51 loading onto the BCR after etoposide
treatment to repress11q23 chromosome translocations.
Figure 5 continued
AT5BIVA or 11–4 cells with split chromosome 11q23 signals are shown. The non-targeting control siRNA (siNT) or siARP8-depleted cells were treated
with DMSO (ctrl) or etoposide for 15 min, washed, and cultured for 6 hr in fresh medium. At least 2,000 cells were analyzed in every experiment. The
average percentages of cells with split signals from four independent experiments are shown. Values represent the means ± SE. ***p<0.001 as
determined by the Z test. The ARP8 knockdown is shown in the gel image on the right. Source data are presented in Figure 5—source data 1. (C, D)
Dual-color FISH analyses of chromosome 11q23 using ARP8-depleted AT5BIVA (C) and 11–4 (D) cells expressing the siARP8-resistant ARP8 wild-type
(WT), S412D, or S412A. The average percentages of the cells with split signals from three independent experiments are shown. Values represent the
means ± SE. ***p<0.001 as determined by the Z test. Source data are presented in Figure 5—source data 1. (E) Dual-color FISH analyses of
chromosome 11q23 using 11–4 cells expressing the siARP8-resistant ARP8 S412A. The cells were treated with/without 10 mM ATM inhibitor (KU55933)
for 2 hr before etoposide treatment. After the cells were washed, KU55933 (5 mM) was added until the cells were harvested. The average percentages
of the cells with split signals from three independent experiments are shown. Values represent the means ± SE from three independent experiments. n.
s.: no significant difference. Source data are presented in Figure 5—source data 1.
DOI: https://doi.org/10.7554/eLife.32222.021
The following source data and figure supplement are available for figure 5:
Source data 1. Source raw data for Figure 5B-E.
DOI: https://doi.org/10.7554/eLife.32222.023
Source data 2. Source raw data for Figure 5—figure supplement 1A and B.
DOI: https://doi.org/10.7554/eLife.32222.024
Figure supplement 1. Dual-color FISH analysis of chromosome 11q23 using a different DNA probe set.
DOI: https://doi.org/10.7554/eLife.32222.022
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Figure 6. ATM, but not ATR, negatively regulates RAD51 loading onto the BCR after etoposide treatment to repress 11q23 chromosome
translocations. (A) ChIP analysis of the RAD51 loading onto the MLL BCR in ATMi or ATRi or a combination of ATMi and ATRi treated 11–4 cells. 11–4
cells were treated with ATMi (10 mM), ATRi (10 mM), or a combination of ATMi and ATRi for 2 hr before etoposide treatment. After washing the cells,
the inhibitors (5 mM) were added until the cells were harvested. The ChIP analysis was performed as described in Figure 4. Values represent the
Figure 6 continued on next page
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Discussion
Our present results are the first to identify ARP8 as the phosphorylation target regulated by ATM
and ATR after the induction of DNA damage by etoposide treatment. ARP8 facilitates the binding of
INO80 and RAD51 to the BCR of the MLL gene, while the phosphorylation of ARP8 suppresses it
through a reduction of its interaction with INO80. The incidence of etoposide-induced 11q23 trans-
locations is reduced by the expression of the phospho-mimicking ARP8 mutant in ATM-deficient
cells. Moreover, the expression of the phospho-deficient ARP8 in ATM-proficient cells increases
chromosome translocations. ATR was not involved in the regulation of RAD51 binding to the BCR
after etoposide treatment. These findings strongly suggest that ATM represses the 11q23 chromo-
some translocations by regulating the binding of INO80 and RAD51 to the BCR of the MLL gene at
functionally appropriate levels, via the phosphorylation of ARP8.
In response to DNA damage, the DNA repair process is facilitated by the phosphorylation of vari-
ous proteins, including DNA repair factors, cell cycle regulators, and chromatin remodeling factors,
through the positive regulation by ATM and ATR (Mare´chal and Zou, 2013) (Cimprich and Cortez,
2008) (Clouaire et al., 2017; Shiloh, 2003; Shiloh and Ziv, 2013). In contrast, Exo1, an exonuclease
for end resection in HR, is also phosphorylated by ATM in response to DNA damage, but to inhibit
its exonuclease activity for the prevention of the untimely generation of ssDNA for RAD51 loading
(Bolderson et al., 2010). In this study, we show that the phosphorylation of ARP8 represses the
binding of INO80 and RAD51 to damaged chromatin (Figures 2 and 4). Importantly, the phosphory-
lation of ARP8 reduced its interaction with INO80 (Figure 3, Figure 3—figure supplements 1 and
2). Since ARP8 is required for the binding of the INO80 complex to damaged chromatin
(Kashiwaba et al., 2010; Saravanan et al., 2012), the reduced interaction of ARP8 with INO80 by
its phosphorylation may repress the binding of INO80 to the damaged chromatin and thus reduce
ssDNA formation and RAD51 loading around damaged sites. ARP8 phosphorylation is significant
from 2 hr after etoposide treatment, which is slower than the phosphorylation of ATM and H2AX.
Therefore, it may also facilitate the dissociation of INO80 from damaged chromatin after the appro-
priate remodeling of damaged chromatin for DNA repair to avoid illegitimate recombination, lead-
ing to chromosome abnormalities. The phosphorylation of various proteins regulated by ATM may
play an important role to prevent chromosome abnormalities, by maintaining the recombination
activity within an appropriate range through both positive and negative regulation of repair
proteins.
The phosphorylation of ARP8 is relatively slow, and occurs more than 2 hr after etoposide treat-
ment, as compared to the early activation of ATM within 1 hr (Bakkenist and Kastan, 2003;
Tanaka et al., 2007). Since the recombinational repair of DSBs starts slowly as compared to the
end-joining repair, which normally begins within 30 min (Mao et al., 2008), this is consistent with the
notion that ARP8 plays an important role in the appropriate regulation of the recombinational repair
proteins. The slower phosphorylation of ARP8 also suggests the involvement of kinases other than
ATM. Indeed, we found that ATR also regulates the etoposide-induced phosphorylation of ARP8.
Moreover, ATRi repressed the phosphorylation of ARP8 especially from 2 hr after the etoposide
treatment. These findings suggest the presence of different regulation systems of ARP8 phosphory-
lation after the induction of DNA damage. The phosphorylation of ARP8 after etoposide treatment
Figure 6 continued
means ± SE from three independent experiments. *p<0.05. **p<0.01. Source data are presented in Figure 6—source data 1. (B) The percentages of
11–4 cells with split chromosome 11q23 signals are shown. 11–4 cells were treated with ATMi (10 mM), ATRi (10 mM), or a combination of ATMi and ATRi
for 2 hr before etoposide treatment. After the cells were washed, the inhibitors (5 mM) were added until the cells were harvested. Dual-color FISH
analyses of chromosome 11q23 were performed as described in Figure 5. Values represent the means ± SE from three independent experiments.
*p<0.05. **p<0.01, ***p<0.001, n.s.: no significant difference.
DOI: https://doi.org/10.7554/eLife.32222.025
The following source data is available for figure 6:
Source data 1. Source raw data for Figure 6A and B.
DOI: https://doi.org/10.7554/eLife.32222.026
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could be regulated by multiple steps and factors for the precise control of DNA repair activity to
maintain chromosome stability.
This study revealed that ATR is likely to be the major kinase responsible for the etoposide-
induced ARP8 phosphorylation. However, unlike the inhibition of ATM, ATR inhibition failed to
increase the RAD51 binding to the BCR of MLL after etoposide treatment (Figure 6), suggesting
that ATR is not involved in the regulation of RAD51 binding to the BCR after etoposide treatment.
Although the mechanism of 11q23 chromosome translocations is still unclear, a specific DNA
sequence and/or chromatin structure of the BCR has been suggested to promote the mis-rearrange-
ment of this region during the repair process (Gole and Wiesmu¨ller, 2015). Therefore, ARP8 phos-
phorylation by ATM functions in the prevention of chromosome translocation at the BCR, while that
by ATR may play roles in the repair of different types of DNA damage not relevant to chromosome
translocations. Further studies are required to clarify the distinct roles of ATM and ATR in the phos-
phorylation of ARP8 after the induction of DNA damage, to coordinate the HR activity for accurate
DNA repair.
Several lines of evidence have suggested the association of HR with genomic instability
(Bishop and Schiestl, 2003; Guirouilh-Barbat et al., 2014; Mizuno et al., 2009; Reliene et al.,
2007; Ruiz et al., 2009). RAD51-deficient vertebrate cells accumulate chromosomal breaks, result-
ing in an early embryonic lethal phenotype (Lim and Hasty, 1996; Sonoda et al., 1998). However,
the overexpression of human RAD51 also leads to genomic instability (Kim et al., 2001;
Marsden et al., 2016; Reliene et al., 2007; Richardson et al., 2004). These findings suggest that
both the down- and up-regulation of the recombination activities through the levels of the RAD51
protein are associated with chromosomal instability. Together with the regulation of the RAD51
function at the protein level, the regulation of the BCR binding by the ATM-regulated phosphoryla-
tion of ARP8 may play an important role in maintaining the local recombination activities within an
appropriate range, to ensure the fidelity of DNA repair and prevent chromosome translocations.
INO80 and ARP8 have been shown to regulate the RAD51 loading to damaged chromatin in yeast
(Tsukuda et al., 2005) (Tsukuda et al., 2009) (van Attikum et al., 2007) (Lademann et al., 2017).
Moreover, the overexpression of human RAD51 leads to the various types of chromosome abnor-
malities (Reliene et al., 2007; Richardson et al., 2004). Therefore, this regulation of HR by ARP8 in
human cells may also be applicable to DSBs in general.
The wild-type and the phospho-deficient mutant of ARP8 show increased interactions with INO80
after etoposide treatment, but the phospho-mimetic mutant does not (Figure 3, and Figure 3—fig-
ure supplements 1 and 2). Human ARP8 contains five insertions in the conserved actin fold domain
(Gerhold et al., 2012) (Figure 1—figure supplement 1B). The S412 residue is located in a major
loop insertion (insertion IV, residues 401–507) (Figure 1—figure supplement 1C). This region lacks
interpretable electron density, suggesting its high flexibility to mediate dynamic protein–protein
interactions (Gerhold et al., 2012). Moreover, the involvement of insertion IV in forming a proper
ARP8-DNA complex has been suggested (Osakabe et al., 2014). Therefore, the phosphorylation of
S412 within insertion IV of ARP8 could affect the binding activity of the INO80 complex to damaged
chromatin, by suppressing the interactions with INO80 and components of damaged chromatin.
Interestingly, ARP8 is conserved from yeast to human, but the 412-SQ motif is conserved only in
higher eukaryotes, and not in yeast, Drosophila and Xenopus (Figure 1—figure supplement 1D).
Although the mechanism by which the ARP8 phosphorylation regulates the activity of the INO80
complex remains to be clarified, the DNA damage-dependent ARP8 phosphorylation may have evo-
lutionary advantages in DNA repair.
Chromosome abnormalities involving the MLL gene are one of the most frequent chromosomal
aberrations observed in secondary leukemia associated with cancer therapy. We have shown that
the etoposide-induced DNA damage in ATM-deficient cells facilitates the illegitimate recombination
at the MLL gene, through the excessive binding of RAD51 and INO80 to the BCR. Our findings high-
light the importance of the ATM-dependent modulation of recombination repair to avert 11q23
chromosome translocations. Further studies to investigate the mechanism that maintains the fidelity
of DNA repair activity, using the chromosome translocations observed in secondary malignancy will
provide new insights into the general mechanisms of carcinogenesis.
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ATM inhibitor (KU55933) Merck Millipore Merck Millipore:Cat# 118500
Chemical compound,
drug
ATR inhibitor IV Merck Millipore Merck Millipore:Cat# 504972
Software, algorithm Metefer 4 MetaCyte Metasystems v 3.11.4 software for FISH analysis
Software, algorithm Image J NIH
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probe for FISH analysis
Cell culture and chemical treatment
The SV40-transformed AT fibroblast cell line AT5BIVA and its ATM-proficient derivative, AT5BIVA
cells reconstituted with chromosome 11 (11-4), were kindly provided by Dr. S. Matsuura (Sun et al.,
2010). The AT5BIVA cells were cultured in Dulbecco’s Modified Eagle’s medium (DMEM, Sigma-
Aldrich), supplemented with 10% fetal bovine serum (FBS, Equitech-Bio, Kerrville, USA). The 11–4
cells were maintained in DMEM supplemented with 10% FBS and 0.2 mg/ml of G418 (Nacalai Tes-
que). The Flp-In T-Rex 11–4 cells were maintained in DMEM, supplemented with 10% tetracycline-
free FBS (Sigma-Aldrich, St. Louis, USA), 10 mg/ml blasticidin S HCl (Gibco, Japan) and 40 mg/ml
hygromycin B (Invitrogen, Carlsbad, USA). The human osteosarcoma U2OS cell line (ATCC) was cul-
tured in Minimum Essential Medium Eagle (MEM, Sigma-Aldrich), supplemented with 10% FBS.
GM0637 cells were cultured in DMEM, supplemented with 10% FBS. Tet-Off ARP8 Nalm-6 cells
were cultured at 37˚C in RPMI-1640, containing GlutaMAX-I (Gibco) and supplemented with 10%
FBS. For the induction of the ARP8 knockout, tetracycline (Sigma-Aldrich) was added to the culture
medium to a final concentration of 2 mg/ml (Osakabe et al., 2014). AT5BIVA, 11–4 cell lines were
kindly provided by Dr. S. Matsuura laboratory, Hiroshima University, Japan. U2OS cell line was pur-
chased from ATCC. GM0637 cell line was kindly provided by Dr. T. Cremer laboratory, LMU, Ger-
many. Tet-Off ARP8 Nalm-6 cell line was kindly provided by Dr. M. Harata laboratory, Tohoku
University, Japan. For the induction of DNA damage, as described elsewhere, the cells were
exposed to 100 mM etoposide (Sigma-Aldrich), unless otherwise stated, for 15 min, washed, and cul-
tured in fresh medium. Dimethylsulfoxide (DMSO) was used as the vehicle for etoposide, and was
present in the cell cultures at a final concentration of 0.1%. Unless otherwise stated, both the ATM
inhibitor KU55933 (Merck Millipore, Billerica, USA) and ATR inhibitor IV VE821 (Merck Millipore)
were used at 10 mM for two hours before etoposide treatment and at 5 mM after the cells were
washed, respectively.
Sun et al. eLife 2018;7:e32222. DOI: https://doi.org/10.7554/eLife.32222 18 of 24
Research article Chromosomes and Gene Expression
Antibodies
The antibodies used for chromatin immunoprecipitation, immunoblotting, and immunofluorescence
staining were rabbit anti-phospho ATM/ATR substrate motif (Cell Signaling
Technology, Danvers, USA), mouse anti-phospho ATM (Rockland, Pottstown, USA), mouse anti-HA,
mouse anti-gH2AX (Merck Millipore), rabbit anti-RAD51 (Bio Academia,Japan), rabbit anti -RPA2 S4/
8 and rabbit anti-INO80 (Bethyl, Montgomery, USA), mouse anti-RPA34 (Lab Vision, Fremont, USA),
rabbit anti-glyceraldehyde-3-phosphate dehydrogenase (anti-GAPDH) (Santa Cruz
Biotechnology, USA), rabbit anti-H2AX (Abcam, UK), and mouse anti-b-actin (Sigma-Aldrich) and
rabbit anti-ARP8 (Osakabe et al., 2014).
RNAi and plasmids
All siRNAs were Ambion Silencer Select siRNAs (Thermo Fisher Scientific,USA). The siRNAs were
s41201 for ARP8, s57219 for ATM, s3638 for CK2, s29257 and s224310 for INO80. Select Negative
Control siRNA was used as the control. The siRNA interference experiments were performed 2 days
after transfection with 0.2–0.3 nM siRNA, using Lipofectamine RNAiMAX (Invitrogen). The pcDNA
3.1 vector bearing the HA-tagged ARP8 was constructed by inserting the PCR-amplified ARP8
cDNA into the NotI/HindIII sites, followed by inserting the PCR-amplified HA between the ApaI and
XhoI sites of pcDNA3.1/Myc-His (-) C. Plasmid transfections were performed using the GeneJuice
transfection reagent (Novagen, Billerica, USA), according to the manufacturer’s instructions. For res-
cue experiments, the siRNA-resistant ARP8 expression vector was co-transfected with the siRNA,
using the Lipofectamine 2000 transfection reagent (Invitrogen) for 2 or 3 days. The mutant vectors
were constructed by site-directed mutagenesis, using the indicated oligonucleotides: For the siRNA-
resistant HA-ARP8 mutant, 5’-ctcaacaaaatgccaccatcgttcagacgtataattgaaaatgtggatg-3’, for the HA-
ARP8 S418A mutant, 5’-TTGCAGCACAGAGCTCAGGGCGATCCTG-3’, and for the S418D mutant,
5’-TTGCAGCACAGAGATCAGGGCGATCCTG-3’. The sequences were confirmed using a BigDye
Terminator v3.1 Cycle Sequencing Kit and an Applied Biosystems Genetic Analyzer, model 3130.
Establishment of stably expressing cells
To generate cells stably expressing U2OS, the pcDNA 3.1 plasmid encoding the HA-tagged wild-
type or S412A mutant of ARP8 was transfected using the GeneJuice transfection reagent, with G418
selection (Nacalai Tesque, Japan). After the confirmation of stable expression by immunofluores-
cence staining and immunoblotting, pools of single clones were used for experiments. For the gen-
eration of the inducible expression of wild-type or phosphorylation mutant ARP8 in 11–4 cells, the
Flp-In System (Thermo Fisher Scientific) was used, according to the manufacturer’s instructions. The
siRNA-resistant HA-tagged wild-type,or S412A ARP8 fragment from pcDNA 3.1 HA-ARP8 was
inserted between the HindIII and KpnI sites of the pcDNA5/FRT/TO vector. For the induction of the
HA-ARP8 expression, a final concentration of 2 mg/ml tetracycline was added for 24 hr.
FISH analysis
FISH analyses were performed using the 11q23 chromosome translocation probe (XL MLL plus,
MetaSystems probes, Germany) and the LSI MLL Dual Color, BreakApart Rearrangement Probe
(Vysis, Abbott Molecular Inc. Abbott park, USA), according to the manufacturers’ protocols. For the
DNA FISH analysis using the probe from Metaystems, the images were acquired on an Axio Imager
Z2 microscope (Carl Zeiss, Germany) equipped with the MetaSystems software. Subsequently, at
least 2000 etoposide-exposed or DMSO-exposed cells were counted by the Metafer platform, Meta-
Cyte, and the cells containing split signals (separated by >1 mm) were monitored. For the DNA FISH
analysis using the probe from Vysis, the images were acquired on a Zeiss AxioplanII microscope
using an AxioCamMRm controlled by Axiovision. At least 200 etoposide-exposed or DMSO-exposed
cells were counted. All FISH analyses were repeated three times.
Chromatin immunoprecipitation and real-time PCR assay
In brief, the cells were fixed by adding formaldehyde to a 1% final concentration for 10 min at 25˚C.
The cells were then sonicated to prepare chromatin suspensions of DNA fragments that were
roughly 300–500 bps in length. Immunoprecipitations were performed using antibodies against
INO80 and RAD51. Normal rabbit IgG was used as the negative control. Real-time PCR reactions
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were performed using SYBR premix Ex Taq (TAKARA, Japan). The dissociation curve analysis of the
melting temperature of the amplified DNA showed that each primer set gave a single, specific prod-
uct. The immunoprecipitation data were normalized to those of a control region in the GAPDH or b-
globin gene, to correct for experimental variation. The relative immunoprecipitation value represents
the ratio of the immunoprecipitated DNA after chemical treatment to the immunoprecipitated DNA
after vehicle treatment. All ChIP analyses were repeated at least three times, and in each experi-
ment, quantitative PCR reactions were performed in duplicate. Values represent the means ± SE.
The primers for real-time PCR were: bt56 forward: 5 ’-TACTCTGAATCTCCCGCA-3’ bt56 reverse:







After fixation in 4% paraformaldehyde in 1X phosphate-buffered saline (PBS) for 10 min at room
temperature, the cells were permeabilized with 0.1% sodium dodecyl sulfate (SDS) 0.5% Triton
X-100 in 1x PBS for 5 min. For the detection of HA-tagged ARP8, fixed cells were incubated for 30
min at 37˚C with a mouse anti-HA antibody (1:600) in 1% bovine serum albumin (BSA)/1 XPBS. Cy3-
conjugated goat anti-mouse (1:1,000, Invitrogen) antibodies were used as the secondary antibodies.
Cells were mounted using Vectashield containing DAPI and observed with a BZ-X700 microscope
(Keyence).
Immunoprecipitation and immunoblotting
The nuclear fraction was prepared as described previously (Liu et al., 2015). The whole cells extracts
were prepared using buffer C (20 mM HEPES pH 7.9, 400 mM NaCl, 1 mM EDTA, 0.1% NP-40, 0.5
mM DTT, 1X protease inhibitor (Roche), 1X phosphatase inhibitor (Nacalai Tesque), 20% glycerol),
and the diluted lysates were used for immunoprecipitation. For immunoprecipitation assay of trans-
fected cells, anti-HA antibody conjugated IgG Dynabeads (Novex) were used, and for the endoge-
nous protein, anti-INO80 antibody, anti-ARP8 antibody, or normal IgG conjugated IgG Dynabeads
were used. The immunoprecipitation analysis was performed at least twice to confirm the results.
The precipitates were electrophoresed through a gel and probed by western blotting with the indi-
cated the antibodies. The intensities of the bands were quantified, using the Image J software.
Proximity ligation assay (PLA)
GM0637 cells were transfected with the HA-tagged wild type or S412A or S412D mutant of ARP8 or
empty vector for 24 hr, fixed with 2% paraformaldehyde in PBS for 10 min at room temperature and
permeabilized with 0.5% Triton X-100 in PBS for 5 min at room temperature. The cells were incu-
bated with the rabbit anti-INO80 and mouse anti-HA antibodies diluted in 0.1% BSA for 30 min at
37˚C in a moist chamber. Proximity ligation was then conducted in situ, according to the manufac-
turer’s instructions (Olink Bioscience, Sweden). We used the PLA probe anti-rabbit PLUS and the
PLA probe anti-mouse MINUS. To visualize the interaction between two proteins, the samples were
incubated for ligation and amplification. After serial SSC (sodium/sodium citrate) washes, nuclei
were stained with DAPI. The slides were mounted with Vectashield (Vector Labs). PLA signals were
detected with an LSM780 confocal microscope (Carl Zeiss), with a 63  1.40 NA plan-apochromat
objective, and counted in at least 400 cells with the Image J software. All PLA analyses were
repeated four times.
Data analysis
Data in all experiments are represented as mean ± SE. Statistical analysis was performed using the
two-tailed unpaired t- test. For the FISH analysis, the percentages of cells with split signals were
determined by the Z test of homogeneity for independent samples. Results reaching p<0.05 were
considered to be statistically significant (*p<0.05, **p<0.01, ***p<0.001).
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